Abstract
Stereotactic ablative body radiotherapy (SABR) is the standard of care for patients with early-stage lung cancer who are unable to undergo surgery. Although SABR is generally well-tolerated, radiation-induced lung injury (RILI) can occur in up to 58% of treated patients, which can be difficult to distinguish from local recurrence in follow-up imaging. Predictive markers that identify patients at greater risk of RILI may aid in the interpretation of post-treatment imaging. In this retrospective study, we investigated whether dosimetric data correlate with the relative volume of post-treatment RILI.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
